Seres Therapeutics to present SER-428 preclinical data at IDWeek

October 15, 2026 7:02 AM

Seres Therapeutics, Inc. (Nasdaq: MCRB) announced it will present preclinical data for SER-428, an investigational oral liquid live biotherapeutic product ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found